Y503-1367 Screening compound: methyl 2-[(4-biphenylyloxy)methyl]-9-methylthieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine-8-carboxylate

Y503-1367 Screening compound: methyl 2-[(4-biphenylyloxy)methyl]-9-methylthieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine-8-carboxylate
Y503-1367 Screening compound: methyl 2-[(4-biphenylyloxy)methyl]-9-methylthieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine-8-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound Y503-1367
methyl 2-[(4-biphenylyloxy)methyl]-9-methylthieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine-8-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y503-1367

Molecular Formula

C23H18N4O3S (C23 H18 N4 O3 S)

Compound Name

methyl 2-[(4-biphenylyloxy)methyl]-9-methylthieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine-8-carboxylate

IUPAC name

methyl 4-({[11'-biphenyl]-4-yloxy}methyl)-12-methyl-10-thia-3568-tetraazatricyclo[7.3.0.0^{26}]dodeca-1(9)24711-pentaene-11-carboxylate

SMILES

Cc1c(C(OC)=O)sc2c1c1nc(COc(cc3)ccc3-c3ccccc3)nn1cn2

InChI

InChI=1S/C23H18N4O3S/c1-14-19-21-25-18(26-27(21)13-24-22(19)31-20(14)23(28)29-2)12-30-17-10-8-16(9-11-17)15-6-4-3-5-7-15/h3-11,13H,12H2,1-2H3

InChI Key

RPMLJPDAFWEMPX-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.785

Distribution Coefficient, logD

4.783

Water Solubility, LogSw

-5.02

Polar Surface Area

60.511

Acid Dissociation Constant (pKa)

26.85

Base Dissociation Constant (pKb)

4.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.04

Y503-1367 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y503-1367 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y503-1367?
Check Price and Availability of Y503-1367, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y503-1367 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y503-1367
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y503-1367
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y503-1367 available by request